StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Oral Care (LISTERINE) by Year

Oral Care (LISTERINE) — International operational growth YoY (%) (%)

Johnson & Johnson Oral Care (LISTERINE): -7.4% in FY2022, down 10.2 pts from a year earlier. No newer figure appears in the documents we track.

Latest, FY2022
-7.4%
Period ended Jan 1, 2023
Change on a year earlier
-10.2 pts
2.8% in FY2021
History
6 years
Since FY2017
Sources
6
Documents cited below

Where the FY2022 figure comes from

“|| Intl | 871 | 1,008 | (13.6) | (7.4) | (6.2)”

Source: Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOral Care (LISTERINE) — International operational growth YoY (%) (%)Year on yearSource
FY2022Jan 1, 2023-7.4%-10.2 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
FY2021Jan 2, 20222.8%-6.8 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
FY2020Jan 3, 20219.6%+6.3 ptsForm 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
FY2019Dec 29, 20193.3%+2.8 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 20180.5%+2.3 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 2017-1.8%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Oral Care (LISTERINE) (%), annual FY2017–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch-oral-care-intl-ops-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.